Liver Disease
Conference Coverage
Rapid core antigen HCV tests could expand accessibility
Low-cost rapid diagnostic testing for HCV plus lab RNA confirmation of negatives may improve access to treatment in countries with limited...
Conference Coverage
The pandemic hurt patients with liver disease in many ways
Conference Coverage
Novel liver dialysis device may safely curb ACLF
The investigational DIALIVE liver dialysis system removes and replaces albumin and filters endotoxins in patients with acute-on-chronic liver...
Conference Coverage
Worse survival with recurrent AIH after transplant
Patients with recurrent autoimmune hepatitis after transplant have a more than 10-fold greater risk for graft failure than those without...
Conference Coverage
Calories may outweigh nutrients in diets for fatty liver
Researchers have debated whether popular low-carbohydrate, high-fat diets might cause more harm than good.
From the Journals
COVID-19 vaccinations may be weakened by liver disease
Testing serology following vaccination contradicts the FDA, which issued a recommendation on May 19 against using antibody tests.
From the Journals
Safety-net burden linked with poorer inpatient cirrhosis outcomes
Even so, hospitalizations and mortality were still higher in Black patients than White patients after controlling for hospitals’ safety-net burden...
From the Journals
Guidelines highlight drug- and herb-induced liver injuries
Leading causes of idiosyncratic drug-induced liver injury include antimicrobials, herbal and dietary supplements, and cancer treatments.
Conference Coverage
Liver transplant outcomes improving for U.S. patients with HIV/HCV
Hepatitis C virus infection no longer confers worse patient survival in the era of DAA therapy, but the population remains underserved.
News
FDA restricts obeticholic acid (Ocaliva) over serious liver injury risk
Before starting obeticholic acid, clinicians should determine whether a patient with PBC has advanced cirrhosis.